Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 2
2009 3
2010 2
2011 5
2012 4
2013 2
2014 4
2015 2
2016 2
2017 7
2018 6
2019 9
2020 11
2021 7
2022 18
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol for neurodegenerative disorders: A comprehensive review.
Bhunia S, Kolishetti N, Arias AY, Vashist A, Nair M. Bhunia S, et al. Front Pharmacol. 2022 Oct 25;13:989717. doi: 10.3389/fphar.2022.989717. eCollection 2022. Front Pharmacol. 2022. PMID: 36386183 Free PMC article. Review.
The profound effect of (9)-tetrahydrocannabinol (THC), the major psychoactive component of cannabis, has led to the discovery of the endocannabinoid system as a molecular target in the central nervous system (CNS). Cannabidiol (CBD), the major non-psychoactive component of …
The profound effect of (9)-tetrahydrocannabinol (THC), the major psychoactive component of cannabis, has led to the discovery of the endocan …
Pharmacology of Medical Cannabis.
Amin MR, Ali DW. Amin MR, et al. Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8. Adv Exp Med Biol. 2019. PMID: 31332738 Review.
The predominant psychotropic component is delta(9)-tetrahydrocannabinol (delta(9)-THC), while the major non-psychoactive ingredient is cannabidiol (CBD). These compounds have been shown to be partial agonists or antagonists at the prototypical cannabinoid receptors, CB1 an …
The predominant psychotropic component is delta(9)-tetrahydrocannabinol (delta(9)-THC), while the major non-psychoactive ingredient is ca …
The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne.
Peyravian N, Deo S, Daunert S, Jimenez JJ. Peyravian N, et al. J Inflamm Res. 2022 May 3;15:2795-2801. doi: 10.2147/JIR.S355489. eCollection 2022. J Inflamm Res. 2022. PMID: 35535052 Free PMC article. Review.
Therefore, the use of natural plant-derived treatments or phytotherapeutics as an alternative or adjuvant to conventional treatments is attractive to patients due to their safety and minimal risk for side effects. Cannabidiol (CBD) is a non-psychoactive phytocannabinoid of …
Therefore, the use of natural plant-derived treatments or phytotherapeutics as an alternative or adjuvant to conventional treatments is attr …
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review.
Cooray R, Gupta V, Suphioglu C. Cooray R, et al. Mol Neurobiol. 2020 Nov;57(11):4878-4890. doi: 10.1007/s12035-020-02054-6. Epub 2020 Aug 19. Mol Neurobiol. 2020. PMID: 32813239 Free PMC article. Review.
Neurodegeneration leading to Parkinson's disease (PD) and Alzheimer's disease (AD) has become a major health burden globally. ...Therefore, understanding the precise molecular cascade following cannabinoid treatment is suggested, focusing especially on gene expression to i …
Neurodegeneration leading to Parkinson's disease (PD) and Alzheimer's disease (AD) has become a major health burden globally. ...Ther …
Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease.
Coles M, Steiner-Lim GZ, Karl T. Coles M, et al. Front Neurosci. 2022 Sep 2;16:962922. doi: 10.3389/fnins.2022.962922. eCollection 2022. Front Neurosci. 2022. PMID: 36117622 Free PMC article. Review.
Alzheimer's disease (AD) is a debilitating neurodegenerative disease characterized by declining cognition and behavioral impairment, and hallmarked by extracellular amyloid-beta plaques, intracellular neurofibrillary tangles (NFT), oxidative stress, neuroinflammation, and neur …
Alzheimer's disease (AD) is a debilitating neurodegenerative disease characterized by declining cognition and behavioral impairment, and hal …
Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.
Philpott HT, O'Brien M, McDougall JJ. Philpott HT, et al. Pain. 2017 Dec;158(12):2442-2451. doi: 10.1097/j.pain.0000000000001052. Pain. 2017. PMID: 28885454 Free PMC article.
Osteoarthritis (OA) is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral neuropathy. Cannabidiol (CBD) is a noneuphoria producing constituent of cannabis that has the potential to relieve pain. ...Prophylact …
Osteoarthritis (OA) is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral n …
Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson's disease.
Muhammad F, Liu Y, Wang N, Zhao L, Zhou Y, Yang H, Li H. Muhammad F, et al. Neurotoxicology. 2022 Dec;93:128-139. doi: 10.1016/j.neuro.2022.09.001. Epub 2022 Sep 13. Neurotoxicology. 2022. PMID: 36108815
Parkinson disease (PD) is the second most progressive neurodegenerative disorder of the central nervous system (CNS) in the elderly, causing motor impediments and cognitive dysfunctions. Dopaminergic (DA) neuron degeneration and alpha-synuclein (alpha-Syn) accumulation in …
Parkinson disease (PD) is the second most progressive neurodegenerative disorder of the central nervous system (CNS) in the elderly, causing …
Emerging potential of cannabidiol in reversing proteinopathies.
Dash R, Ali MC, Jahan I, Munni YA, Mitra S, Hannan MA, Timalsina B, Oktaviani DF, Choi HJ, Moon IS. Dash R, et al. Ageing Res Rev. 2021 Jan;65:101209. doi: 10.1016/j.arr.2020.101209. Epub 2020 Nov 9. Ageing Res Rev. 2021. PMID: 33181336 Review.
Along with oxidative stress and neuroinflammation, disruption in protein homeostasis (proteostasis), a network that constitutes protein surveillance system, plays a pivotal role in the pathobiology of these dementia disorders. Cannabidiol (CBD), a non-psychotropic phytocan …
Along with oxidative stress and neuroinflammation, disruption in protein homeostasis (proteostasis), a network that constitutes protein surv …
Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures.
Dearborn JT, Nelvagal HR, Rensing NR, Takahashi K, Hughes SM, Wishart TM, Cooper JD, Wong M, Sands MS. Dearborn JT, et al. Sci Rep. 2022 Jul 4;12(1):11286. doi: 10.1038/s41598-022-15134-5. Sci Rep. 2022. PMID: 35789177 Free PMC article.
Cannabidiol (CBD) has gained attention as a therapeutic agent and is purported to have immunomodulatory, neuroprotective, and anti-seizure effects. ...It is possible that a higher dose of CBD could also reduce neurodegeneration and seizure frequency....
Cannabidiol (CBD) has gained attention as a therapeutic agent and is purported to have immunomodulatory, neuroprotective, and anti-se …
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
Peres FF, Lima AC, Hallak JEC, Crippa JA, Silva RH, Abílio VC. Peres FF, et al. Front Pharmacol. 2018 May 11;9:482. doi: 10.3389/fphar.2018.00482. eCollection 2018. Front Pharmacol. 2018. PMID: 29867488 Free PMC article. Review.
Cannabidiol is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory, and neuroprotective effects. ...Here, we review these clinical and pre-clinical studies and draw attention to the potential of cannabidiol …
Cannabidiol is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory, and ne …
83 results